Skip to main content
CGEN logo
CGEN
(NASDAQ)
Compugen Ltd.
$2.26-- (--)
Loading... - Market loading

Compugen (CGEN) Stock Price & Financial Analysis

Compugen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.19 - $2.28
52-Week High$2.38
52-Week Low$1.13
Open$2.20
Volume205.50K
Average Volume (3M)205.50K
Market Cap212.02M
Shares Outstanding93.82M
P/E Ratio (TTM)5.84
Price to Sales (P/S)2.84
Price to Book (P/B)2.01
EV/EBITDA3.79
Revenue (TTM)72.76M
Net Income (TTM)35.34M
Free Cash Flow (TTM)31.33M
EPS (TTM)$0.37
Profit Margin48.57%
Operating Margin43.05%
Return on Equity (ROE)34.40%
Debt to Equity0.03
50-Day MA$1.96
200-Day MA$1.69
52-Week Change56.03%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Compugen

What is the current stock price for CGEN?

As of the latest trading session, CGEN stock trades at $2.26. The 52-week range is $1.13–$2.38, with a day range of $2.19–$2.28.

What is the P/E ratio for CGEN?

Compugen's trailing P/E ratio is 5.8, meaning investors pay $5.8 for every $1 of annual earnings. Compugen operates in the Healthcare sector.

Does CGEN pay dividends?

Compugen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CGEN?

Based on 1 analyst, the consensus for CGEN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CGEN?

Compugen's market capitalization is $212.0M, classifying it as a micro-cap company. Compugen operates in the Healthcare sector within the Biotechnology industry.